Nov 22, 2017
Ampio Announces Publication of Ampion(TM) Treatment of Severe Osteoarthritis of the Knee as a Feature Article in Orthopedics Peer-Reviewed Journal
Nov 16, 2017
Ampio Pharmaceuticals, Inc. Announces Continued Listing Plan Accepted by NYSE American
Nov 15, 2017
Ampio Announces Start of Open Label Extension Study to Support Commercial Label of Repeat Administration of Ampion(TM) in Severe Osteoarthritis of the Knee
Oct 18, 2017
Ampio Pharmaceuticals, Inc. Announces Closing of Registered Direct Offering
Oct 16, 2017
Ampio Pharmaceuticals, Inc. Announces Pricing of Registered Direct Offering
Sep 18, 2017
Ampio Completes Enrollment of Patients in 12-Week Pivotal Trial
Sep 08, 2017
Ampio Pharmaceuticals, Inc. Announces Annual Shareholder Meeting
Sep 07, 2017
Ampio Discloses Receipt of Notice from NYSE American and Has Until March 1, 2019, to Gain Compliance
Aug 09, 2017
Daily Technical Summary Reports on Biotech Stocks -- Axovant Sciences, Ampio Pharma, ImmunoCellular Therapeutics, and Synthetic Biologics
Aug 08, 2017
Ampio Announces the Allowance of a Composition and Methods Patent in the USA Using Ampion(TM) in Conjunction with Stem Cells
Jun 22, 2017
Ampio Injects First Patient in Final Pivotal Clinical Trial for Ampion(TM) BLA
Jun 12, 2017
Ampio Announces Appointment of Interim Chief Financial Officer
Jun 07, 2017
Ampio Pharmaceuticals, Inc. Announces Closing of Registered Direct Offering
Jun 02, 2017
Ampio Pharmaceuticals, Inc. Announces Pricing of Registered Direct Offering